Gu, R., Liu, F., Zou, D., Xu, Y., Lu, Y., Liu, B., . . . Wang, J. (2020). Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia. J Hematol Oncol.
Citación estilo ChicagoGu, Runxia, et al. "Efficacy and Safety of CD19 CAR T Constructed With a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia." J Hematol Oncol 2020.
Cita MLAGu, Runxia, et al. "Efficacy and Safety of CD19 CAR T Constructed With a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia." J Hematol Oncol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.